Founded in 1995, Mankind Pharma Limited has emerged as a leading player in the pharmaceutical industry, specializing in the development, manufacturing, and distribution of diverse pharmaceutical formulations across acute and chronic therapeutic segments. Additionally, the company offers a range of consumer healthcare products.
In this article, we delve into the comprehensive profile of Mankind Pharma Limited, exploring its journey, key achievements, product portfolio, market presence, and impact within the healthcare sector. Join us as we uncover everything you need to know about this dynamic and innovative pharmaceutical company.
About Mankind Pharma
Mankind Pharma Limited has established itself as a dominant force in the Indian pharmaceutical market, boasting impressive leadership rankings and a robust presence in various therapeutic segments. Over the last five years, the company has consistently held the top position in prescriptions and secured the distinction of being the youngest among the top five players in the Indian Pharmaceutical Market (IPM). Mankind Pharma is ranked fourth by value in the IPM and has achieved significant market success with four consumer healthcare brands leading their respective categories. The company’s focus on acute and chronic therapeutic areas such as anti-infectives, cardiovascular, gastrointestinal, anti-diabetic, neuro/CNS, vitamins/minerals/nutrients, and respiratory has yielded remarkable results, especially evident in its outperformance in chronic therapies during the 9MFY24.
Mankind Pharma’s sales mix in Q3FY24 highlights its diversified portfolio, with significant contributions from anti-infectives, cardiovascular, gastrointestinal, and respiratory segments. The company’s extensive brand portfolio includes several leading brands like Manforce (Rx), Moxikind-CV, Amlokind-AT, and Unwanted-Kit, among others, many of which have achieved substantial domestic sales figures exceeding ₹200 crores. With 22 brands surpassing the ₹100 crore mark, Mankind Pharma continues to demonstrate its prowess and innovation in the pharmaceutical industry.
How to Purchase Mankind Pharma?
Below are the trading platforms that you can use to purchase Mankind Pharma shares:
➤ Zerodha
➤ Upstox
➤ Groww
➤ AngelOne
➤ ICICIDirect
When | Maximum Price | Minimum Price |
April 2024 | 2,527.20 | 2,197.57 |
May 2024 | 2,489.85 | 2,165.09 |
June 2024 | 2,579.49 | 2,243.03 |
July 2024 | 2,553.69 | 2,220.60 |
August 2024 | 2,655.84 | 2,309.43 |
September 2024 | 2,762.07 | 2,401.80 |
October 2024 | 2,707.91 | 2,354.71 |
November 2024 | 2,789.15 | 2,425.35 |
December 2024 | 2,858.88 | 2,485.98 |
What did we learn?
- 1 About Mankind Pharma
- 2 How to Purchase Mankind Pharma?
- 3 Mankind Pharma Share Price Prediction 2024 – 2030
- 4 Financial Condition of Mankind Pharma: Last 5 Years
- 5 FAQs
- 5.1 What is Mankind Pharma’s current market capitalization?
- 5.2 What is the current share price target for Mankind Pharma?
- 5.3 What is Mankind Pharma’s projected share price target for 2025?
- 5.4 What is Mankind Pharma’s projected share price target for 2030?
- 5.5 What is Mankind Pharma’s current price-to-earnings (P/E) ratio?
- 5.6 What is Mankind Pharma’s dividend payout percentage?
- 5.7 How has Mankind Pharma’s sales grown over the past decade?
- 5.8 What has been Mankind Pharma’s compounded profit growth rate over the last five years?
- 6 Conclusion: Mankind Pharma’s Growth Trajectory and Investment Outlook